Jarrett Disbrow
CIK: 0001640724
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AYTU BIOPHARMA, INC
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 28, 2026AYTU
AYTU BIOPHARMA, INC
Award(A)Direct15K shares- - Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
Award(A)Direct19.6K shares- - Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
Award(A)Direct12.5K shares- - Jun 9, 2025AYTU
AYTU BIOPHARMA, INC
Purchase(P)Direct16.7K shares at avg. $1.50$25K - Nov 6, 2024AYTU
AYTU BIOPHARMA, INC
Award(A)DirectEmployee Stock Option (Right to Buy)
7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | Award(A) | 15,000 | - | $0 | Direct |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | Award(A) | 19,606 | - | - | Direct |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | Award(A) | 12,500 | - | - | Direct |
| Jun 9, 2025 | AYTU AYTU BIOPHARMA, INC | Purchase(P) | 16,666 | $1.50 | $24,999 | Direct |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | Award(A) Employee Stock Option (Right to Buy) | 7,000 | - | - | Direct |
1-5 of 5 transactions
About Disbrow Jarrett
Disbrow Jarrett (SEC CIK 0001640724) files insider reports with the SEC as Chief Business Officer of AYTU BIOPHARMA, INC (AYTU).
Signal8 holds 4 ownership filings by Disbrow Jarrett, all Form 4s, filed between Nov 8, 2024 and Jul 30, 2026. Those filings report 5 transactions, from Nov 6, 2024 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Disbrow Jarrett's filings is in DENVER, CO.
Recent filings by Disbrow Jarrett
Other insiders filing for AYTU BIOPHARMA, INC (AYTU)
- Disbrow Joshua R., Chief Executive Officer
- PYSZCZYMUKA GREG, Chief Commercial Officer
- Selhorn Ryan J, Chief Financial Officer
- LIU VIVIAN H, Director
- JAIN ABHINAV, Director
- DOCKERY CARL, Director